Short Interfering RNA against Transient Receptor Potential Vanilloid 1 Attenuates Cisplatin-Induced Hearing Loss in the Rat

Cisplatin, a chemotherapeutic agent of choice for the treatment of solid tumors, produces hearing loss in approximately half a million new cancer patients annually in the United States. The hearing loss is due, in part, to increased generation of reactive oxygen species (ROS) in the cochlea, leading...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Mukherjea, Debashree, Jajoo, Sarvesh, Whitworth, Craig, Bunch, Jennifer R., Turner, Jeremy G., Rybak, Leonard P., Ramkumar, Vickram
Formato: Artigo
Idioma:Inglês
Publicado: Society for Neuroscience 2008
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2865180/
https://ncbi.nlm.nih.gov/pubmed/19052196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.1307-08.2008
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares